Abstract
Rhabdomyosarcoma (RMS) is the most common orbital malignancy in childhood. Embryonal RMS and alveolar RMS are the two most common histologic subtypes of RMS, and embryonal RMS is the most common subtype of orbital RMS. The clinical presentation of orbital RMS depends on the tumor location in the orbit. Diagnosis is chiefly made through open biopsy, and complete initial tumor resection is uncommon because of the risk of ocular morbidity. The treatment of orbital RMS requires a coordinated effort by the disciplines of ophthalmology, pathology, pediatric oncology, and radiation oncology. Because of advances in the planning and administration of chemotherapy and radiation therapy, the outcome for patients with orbital RMS has improved; the 3-year failure-free survival rate is greater than 90%, and the 3-year overall survival rate is 100%. Continued improvements in therapy are being investigated in an effort to decrease the risk of treatment-related late effects, such as cataracts and facial asymmetry.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Gurney JG, Young JL, Roffers SD, et al. Soft tissue sarcomas. In: Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR, editors. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995. Bethesda, MD: National Cancer Institute SEER Program, 1999. NIH Pub. No. 99-4649.
Arndt CAS, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 1999;341:342–52.
Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions. The 2002 Montgomery lecture, part 1. Ophthalmology 2004;111:997–1008.
Sorensen PHB, Lynch JC, Qualman SJ, et al. PAX3–FKHR and PAX7–FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children’s Oncology Group. J Clin Oncol 2002;20:2672–9.
Crist WM, Anderson JR, Meza JL, et al. Intergroup Rhabdomyosarcoma Study—IV: results for patients with nonmetastatic disease. J Clin Oncol 2001;19:3091–102.
Kodet R, Newton WA, Hamoudi AB, et al. Orbital rhabdomyosarcomas and related tumors in childhood: relationship of morphology to prognosis—an Intergroup Rhabdomyosarcoma Study. Med Pediatr Oncol 1997;29:51–60.
Raney RB, Anderson JR, Barr FG, et al. Rhabdomyosarcoma and undifferentiated sarcoma in the first 2 decades of life: a selective review of Intergroup Rhabdomyosarcoma Study Group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol 2001;23:215–20.
Sohaib SA, Moseley I, Wright JE. Orbital rhabdomyosarcoma—the radiological characteristics. Clin Radiol 1998;53:357–62.
Karcioglu ZA, Hadjistilianou D, Rozans M, et al. Orbital rhabdomyosarcoma. Cancer Control 2004;11:328–33.
Park K, van Rijn R, McHugh K. The role of radiology in pediatric soft tissue sarcomas. Cancer Imaging 2008;8:102–15.
Breneman JC, Lyden E, Pappo AS, et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma—a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 2003;21:78–84.
Maurer HM, Beltangady M, Gehan EA, et al. The Intergroup Rhabdomyosarcoma Study—I. A final report. Cancer 1988;61:209–20.
Maurer HM, Gehan EA, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study—II. Cancer 1993;71:1904–22.
Crist W, Gehan EA, Ragab AH, et al. The third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995;13:610–30.
Oberlin O, Rey A, Anderson J, et al. Treatment of orbital rhabdomyosarcomas: survival and late effects of treatment—results of an international workshop. J Clin Oncol 2001;19:197–204.
Punyko JA, Mertens AC, Gurney JG, et al. Long-term medical effects of childhood and adolescent rhabdomyosarcoma: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 2005;44:643–53.
Sung L, Anderson JR, Donaldson SS, et al. Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. Eur J Cancer 2004;40:1878–85.
Raney RB, Anderson JR, Kollath J, et al. Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: report from the Intergroup Rhabdomyosarcoma Study—III, 1984–1991. Med Pediatr Oncol 2000;34:413–20.
Fiorillo A, Migliorati R, Vassallo P, et al. Radiation late effects in children treated for orbital rhabdomyosarcoma. Radiother Oncol 1998;53:143–8.
Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 2007;25:953–64.
Timmermann B, Schuck A, Niggli F, et al. Spot-scanning proton therapy for malignant soft tissue tumors in childhood: first experiences at the Paul Scherrer Institute. Int J Radiat Oncol Biol Phys 2007;67:497–504.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Huh, W.W., Mahajan, A. (2010). Multidisciplinary Management of Orbital Rhabdomyosarcoma. In: Esmaeli, B. (eds) Ophthalmic Oncology. M.D. Anderson Solid Tumor Oncology Series, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-0374-7_4
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0374-7_4
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-0373-0
Online ISBN: 978-1-4419-0374-7
eBook Packages: MedicineMedicine (R0)